Heparin prevents Zika virus induced-cytopathic effects in human neural progenitor cells

Ghezzi, Silvia, Cooper, Lynsay C ORCID: 0000-0002-5100-5261, Rubio, Alicia, Pagani, Isabel, Capobianchi, Maria R, Ippolito, Giuseppe, Pelletier, Julien, Meneghetti, Maria C, Lima, Marcelo A., Skidmore, Mark A., Broccoli, Vania, Yates, Edwin A. and Vicenzi, Elisa (2017) Heparin prevents Zika virus induced-cytopathic effects in human neural progenitor cells. Antiviral Research, 140. pp. 13-17. doi:10.1016/j.antiviral.2016.12.023

Preview

Text (Peer-reviewed version) 10072-Cooper-(2017)-Heparin-prevents-Zika-virus-induced-cytopathic-effects.pdf - Accepted Version Available under License Creative Commons Attribution Non-commercial No Derivatives 4.0. Download (379kB) | Preview

Abstract

The recent Zika virus (ZIKV) outbreak, which mainly affected Brazil and neighbouring states, demonstrated the paucity of information concerning the epidemiology of several flaviruses, but also highlighted the lack of available agents with which to treat such emerging diseases. Here, we show that heparin, a widely used anticoagulant, while exerting a modest inhibitory effect on Zika Virus replication, fully prevents virus-induced cell death of human neural progenitor cells (NPCs).

Item Type:	Article
Article Type:	Article
Uncontrolled Keywords:	Zika virus (ZIKV); Neural progenitor cells; Heparin; Cell death
Subjects:	R Medicine > RM Therapeutics. Pharmacology
Divisions:	Schools and Research Institutes > School of Education and Science
Research Priority Areas:	Place, Environment and Community
Depositing User:	Lynsay Cooper
Date Deposited:	25 Aug 2021 14:09
Last Modified:	31 Aug 2023 08:58
URI:	https://eprints.glos.ac.uk/id/eprint/10072

University Staff: Request a correction | Repository Editors: Update this record